Veradermics, Incorporated
MANE NYSEHealthcare ★★★★★Latest Earnings FY2026 Q3 Above forecast↑
Date
Nov 10, 2026
ET
EPS Est.
-0.56
EPS Actual
-0.50
Revenue Est.
--
Revenue Actual
--
The next earnings date has not been announced yet; it is usually confirmed within weeks after the fiscal quarter ends.
Company Overview
Veradermics, Incorporated (ticker MANE) is listed on NYSE with a market cap of about $5.47B. In the last 4 reported quarters, EPS beat consensus estimates 3 times.
Actual EPS TrendRecently5Term · Dec 3, 2025 → FY2026 Q3
Dec 3, 2025Range: -1.63 ~ -0.50FY2026 Q3
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Nov 10, 2026 | FY2026 Q3 | -0.56 | Above forecast↑-0.50 | -- | -- |
| Aug 11, 2026 | -- | -0.65 | Above forecast↑-0.58 | -- | -- |
| May 12, 2026 | -- | -0.56 | Below forecast↓-1.32 | -- | -- |
| Feb 25, 2026 | -- | -1.81 | Above forecast↑-1.63 | -- | -- |
| Dec 3, 2025 | -- | -- | -1.63 | -- | -- |
Original Filings (SEC)
Quarterly10-Q · 2026-11-10 ↗
Earnings Release8-K · 2026-11-10 ↗
Quarterly10-Q · 2026-08-11 ↗
Earnings Release8-K · 2026-08-11 ↗
Quarterly10-Q · 2026-05-12 ↗
Earnings Release8-K · 2026-05-12 ↗
Annual10-K · 2026-03-30 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
